Amerant Bancorp Inc.
AMTB NYSE National Commercial Banks Financials FY2016βFY2025
What Amerant Bancorp Inc. does
No business description yet.
- Legal name
- Amerant Bancorp Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 27, 2026
- Accession Β· CIK
- 0001734342-26-000017
0001734342
Revenue and margins
Amerant Bancorp Inc. had $439M of revenue in fiscal 2025, up 30.8% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 9.6% a year. Loss periods are shown in red.
Returns and efficiency
For banks, return on equity and the efficiency ratio (costs as a share of revenue) say most about how well the business runs.
Dividends, buybacks and share count
Amerant Bancorp Inc. returned $48.1M to shareholders in fiscal 2025, 37% of free cash flow. The diluted share count rose 16.7%.
Balance sheet
Loans, deposits and capital at each fiscal year end.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Loans, net | $5.3B | $6.8B | $6.8B | $7.1B | $6.5B |
| Deposits | $5.6B | $7.0B | $7.9B | $7.9B | $7.8B |
| Loans / deposits | 94.8% | 96.2% | 85.9% | 90.9% | 83.9% |
| Total assets | $7.6B | $9.1B | $9.7B | $9.9B | $9.8B |
| Shareholders' equity | $832M | $706M | $736M | $890M | $939M |
| Goodwill | $19.5M | $19.5M | $19.2M | $19.2M | $19.2M |
| Provision / loans | β0.3% | 0.2% | 0.9% | 0.8% | 0.7% |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $254M | $281M | $273M | $270M | $263M | $326M | $334M | $414M | $336M | $439M |
| Net interest income | $192M | $210M | $219M | $213M | $190M | $205M | $267M | $326M | $326M | $361M |
| Noninterest income | $62.3M | $71.5M | $53.9M | $57.1M | $73.5M | $121M | $67.3M | $87.5M | $9.9M | $78.6M |
| Noninterest expense | $198M | $208M | $215M | $209M | $179M | $198M | $241M | $311M | $299M | $331M |
| Provision for credit losses | $22.1M | β$3.5M | $0.4M | β$3.2M | $88.6M | β$16.5M | $13.9M | $61.3M | $60.5M | $42.6M |
| Interest expense | $46.9M | $63.6M | $90.3M | $99.9M | $71.0M | $42.7M | $72.1M | $222M | β | β |
| Pretax income | $33.8M | $77.0M | $57.6M | $64.0M | β$4.3M | $144M | $78.6M | $41.3M | β$24.1M | $66.1M |
| Income tax | $10.2M | $34.0M | $11.7M | $12.7M | β$2.6M | $33.7M | $16.6M | $10.5M | β$8.3M | $13.7M |
| Net income | $23.6M | $43.1M | $45.8M | $51.3M | β$1.7M | $113M | $63.3M | $32.5M | β$15.8M | $52.4M |
| Diluted EPS | $0.55 | $1.01 | $1.08 | $1.20 | β$0.04 | $3.01 | $1.85 | $0.96 | β$0.44 | $1.26 |
| Diluted shares | 0.04B | 0.00B | 0.00B | 0.00B | 0.04B | 0.04B | 0.03B | 0.03B | 0.04B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | $75.3M | $73.3M | $62.2M | $78.4M | $57.2M | $67.4M | β$49.2M | $26.7M | $82.2M | $137M |
| Capital expenditure | $8.5M | $8.6M | $10.0M | $14.3M | $5.6M | $6.6M | $10.6M | $10.9M | $7.4M | $7.7M |
| Free cash flow | $66.7M | $64.7M | $52.1M | $64.1M | $51.7M | $60.9M | β$59.8M | $15.8M | $74.8M | $129M |
| Depreciation and amortization | $9.1M | $9.0M | $8.5M | $7.1M | $9.4M | $7.3M | $5.9M | $6.8M | $6.6M | $6.7M |
| Stock-based compensation | $0.0M | $0.0M | $0.2M | $6.4M | $2.3M | $4.8M | $5.8M | $6.8M | $5.0M | $5.0M |
| Acquisitions | β | $0.0M | $0.0M | $14.4M | $0.0M | $1.0M | $0.0M | $2.0M | $0.0M | $0.0M |
| Share buybacks | β | β | β | $0.0M | $0.0M | $36.3M | $72.1M | $4.9M | $7.6M | $33.0M |
| Dividends paid | $0.0M | $0.0M | $40.0M | $0.0M | $0.0M | $0.0M | $12.2M | $12.1M | $12.8M | $15.1M |
| Dividends and buybacks | $0.0M | $0.0M | $40.0M | $0.0M | $0.0M | $36.3M | $84.3M | $17.0M | $20.4M | $48.1M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $135M | $153M | $85.7M | $121M | $214M | $274M | $291M | $322M | $590M | $470M |
| Loans, net | β | $6.0B | $5.9B | $5.7B | $5.7B | $5.3B | $6.8B | $6.8B | $7.1B | $6.5B |
| Deposits | β | $6.3B | $6.0B | $5.8B | $5.7B | $5.6B | $7.0B | $7.9B | $7.9B | $7.8B |
| Property and equipment, net | β | $129M | $124M | $129M | $110M | $37.9M | $41.8M | $43.6M | $31.8M | $23.0M |
| Goodwill | β | $19.2M | $19.2M | $19.5M | $19.5M | $19.5M | $19.5M | $19.2M | $19.2M | $19.2M |
| Total assets | β | $8.4B | $8.1B | $8.0B | $7.8B | $7.6B | $9.1B | $9.7B | $9.9B | $9.8B |
| Total liabilities | β | $7.7B | $7.4B | $7.2B | $7.0B | $6.8B | $8.4B | $9.0B | $9.0B | $8.8B |
| Shareholders' equity | $705M | $753M | $747M | $835M | $783M | $832M | $706M | $736M | $890M | $939M |
| Margins | ||||||||||
| Net margin | 9.3% | 15.3% | 16.8% | 19.0% | β0.7% | 34.7% | 19.0% | 7.8% | β4.7% | 11.9% |
| FCF margin | 26.3% | 23.0% | 19.1% | 23.7% | 19.6% | 18.7% | β17.9% | 3.8% | 22.3% | 29.4% |
| Net interest share of revenue | 75.5% | 74.6% | 80.3% | 78.9% | 72.1% | 63.0% | 79.9% | 78.9% | 97.0% | 82.1% |
| Efficiency ratio | 78.0% | 73.8% | 78.8% | 77.5% | 68.0% | 60.9% | 72.3% | 75.2% | 89.2% | 75.2% |
| Returns | ||||||||||
| Return on equity | 3.3% | 5.9% | 6.1% | 6.5% | β0.2% | 14.0% | 8.2% | 4.5% | β1.9% | 5.7% |
| Return on assets | β | 0.5% | 0.6% | 0.6% | β0.0% | 1.5% | 0.8% | 0.3% | β0.2% | 0.5% |
| Return on tangible equity | 3.3% | 5.9% | 6.3% | 6.3% | β0.2% | 13.9% | 9.2% | 4.5% | β1.8% | 5.7% |
| Growth | ||||||||||
| Revenue growth | β | 10.6% | β2.9% | β1.0% | β2.7% | 23.9% | 2.5% | 24.0% | β18.9% | 30.8% |
| Net income growth | β | 82.6% | 6.4% | 12.0% | β103.4% | β | β43.9% | β48.7% | β148.5% | β |
| EPS growth | β | 83.6% | 6.9% | 11.1% | β103.3% | β | β38.5% | β48.1% | β145.8% | β |
| FCF growth | β | β3.1% | β19.4% | 23.1% | β19.4% | 17.8% | β198.2% | β | 373.7% | 72.8% |
| Share count change | β | β99.9% | 0.0% | 0.9% | 97,189.5% | β10.1% | β9.0% | β1.4% | 6.2% | 16.7% |
| Financial health | ||||||||||
| Loans / deposits | β | 94.8% | 97.1% | 98.9% | 100.0% | 94.8% | 96.2% | 85.9% | 90.9% | 83.9% |
| Provision / loans | β | β0.1% | 0.0% | β0.1% | 1.5% | β0.3% | 0.2% | 0.9% | 0.8% | 0.7% |
| Capital allocation | ||||||||||
| Capex / revenue | 3.4% | 3.1% | 3.7% | 5.3% | 2.1% | 2.0% | 3.2% | 2.6% | 2.2% | 1.8% |
| Stock comp / revenue | 0.0% | 0.0% | 0.1% | 2.4% | 0.9% | 1.5% | 1.7% | 1.6% | 1.5% | 1.1% |
| Payouts / FCF | 0.0% | 0.0% | 76.8% | 0.0% | 0.0% | 59.7% | β | 107.7% | 27.2% | 37.2% |
| Quality scores | ||||||||||
| Accruals ratio | β | β0.4% | β0.2% | β0.3% | β0.7% | 0.6% | 1.3% | 0.1% | β1.0% | β0.9% |
Source: SEC EDGAR XBRL filings (CIK 0001734342). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.